Impact of the minimum pricing policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia

P Mcmanus, Donald Birkett, J Dudley, A Stevens

    Research output: Contribution to journalArticle

    41 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)295-300
    Number of pages6
    JournalPharmacoepidemiology and Drug Safety
    Volume10
    Publication statusPublished - 2001

    Cite this